Scientists investigate several techniques to achieve successful gene therapy

San Jose, Calif.--May 2, 2003--As the dismal status of the entire biotech market dissolves numerous potentially lucrative partnerships, many companies developing gene therapy are focusing their R&D efforts on only a few key products.

The idea is to have enough therapies in the pipeline to balance inevitable failures, but not so many that they drain the already strained financial resources.

"The primary difficulty in developing clinically useful gene therapies has been designing a delivery system that delivers sufficient quantities of therapeutic DNA into enough cells to be expressed at levels that affect the disease being treated," states Technical Insights Analyst Katherine Austin.

Other approaches work by stimulating an immune response, mediating specific cell killing, activating a pro-drug, or producing a molecular decoy required for the replication of a virus. DNA vaccines are also in clinical trials for various forms of cancer and infectious disease such as herpes, hepatitis, and AIDS.

The techniques currently vying for the position of successful gene therapy delivery system include viral vectors, ex vivo cell transfection, liposomal vectors, artificial chromosomes, matrix vectors, genetically engineered cells, gene activators, bacterial vectors, and naked DNA.

Research is on to investigate methods such as transcription factors, antisense inhibition or RNA interference, and gene repair to regulate expression without the transfer of genes. Vectors that target particular tissue and cell types to avoid the systemic exposure and side effects such as those seen in current chemotherapy protocols are also in the pipeline.

As vector systems demonstrate success in clinical trials and clinical applications for gene therapy are developed, the cancer, vascular diseases and cystic fibrosis markets are likely to be the first to reap financial benefits from gene therapy.

"Once the first successful products are on the

Contact: Julia Paulson
Technical Insights

Page: 1 2

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: